FDA aims to strengthen oversight of compounded drug manufacturing

BioPharma Dive-Jan 4, 2018

Since a deadly meningitis outbreak in 2012 that prompted new scrutiny of drug compounding, the FDA has conducted over 400 inspections of compounding pharmacies and observed problematic conditions in the "vast majority" of those visits. "The FDA's experience in monitoring pharmacy compounding has demonstrated ...